Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00020332 · ClinicalTrials.gov registry record · Phase 1
Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer
A Phase 1 study of Breast Cancer, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT00020332: Completed Phase 1 study of Breast Cancer, sponsored by National Cancer Institute (NCI).
NCT00020332 is a Phase 1 study of Breast Cancer that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00020332, a Phase 1 study of Breast Cancer, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have locally advanced or metastatic breast cancer.
Conditions Studied
Interventions
- DRUG docetaxel
- DRUG alvocidib
Study Locations (1)
Maryland
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10 |
| Est. Completion | 2003-03 |
| Phase | Phase 1 |
What the finished NCT00020332 record still lists
NCT00020332 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which docetaxel is the first listed.
NCT00020332 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00020332 about?
NCT00020332 is a clinical study titled "Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have locally adva...
What is the current status of trial NCT00020332?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-10. Estimated completion is 2003-03.
What conditions does trial NCT00020332 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00020332?
The interventions under investigation include: docetaxel (DRUG), alvocidib (DRUG).
Who is sponsoring clinical trial NCT00020332?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00020332 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VS-6766+Abema+Fulv in Met HR+/HER- BC
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia